| Stage | GBX | % of rev | SBH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $591M | 100.00% | $935M | 100.00% | SBH ×1.58 |
| Gross profit | $80M | 13.50% | $490M | 52.41% | SBH +38.9pp |
| Operating income | $26M | 4.31% | $86M | 9.24% | SBH +4.9pp |
| Pre-tax income | $6M | 1.05% | $73M | 7.77% | SBH +6.7pp |
| Net income | $13M | 2.18% | $54M | 5.78% | SBH +3.6pp |
| Stage | GBX | SBH | Gap · A − B |
|---|---|---|---|
| Revenue | $591M100.00% | $935M100.00% | SBH ×1.58 |
| Gross profit | 13.50%$80M | 52.41%$490M | SBH +38.9pp |
| Operating income | 4.31%$26M | 9.24%$86M | SBH +4.9pp |
| Pre-tax income | 1.05%$6M | 7.77%$73M | SBH +6.7pp |
| Net income |
| 2.18%$13M |
| 5.78%$54M |
| SBH +3.6pp |
No disclosed counterparties: GBX, SBH.